| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 25.480 | 24.677 | 7.650 | 2.067 | 39.434 | 37.743 | 61.952 | 46.626 |
| Total Income - EUR | - | - | 25.569 | 24.859 | 7.821 | 2.112 | 39.458 | 37.917 | 62.097 | 46.628 |
| Total Expenses - EUR | - | - | 22.970 | 19.439 | 6.739 | 6.057 | 14.071 | 42.241 | 51.457 | 68.389 |
| Gross Profit/Loss - EUR | - | - | 2.599 | 5.420 | 1.081 | -3.946 | 25.386 | -4.324 | 10.640 | -21.761 |
| Net Profit/Loss - EUR | - | - | 2.344 | 5.174 | 1.005 | -3.986 | 24.227 | -5.287 | 8.971 | -21.761 |
| Employees | - | - | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Clinres Farmacija Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 1.448 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 5.894 | 11.786 | 8.653 | 4.424 | 47.850 | 46.959 | 35.485 | 27.321 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 2.224 | 3.818 | 4.878 | 619 | 29.976 | 24.002 | 16.696 | 15.985 |
| Cash | - | - | 3.671 | 7.967 | 3.774 | 3.805 | 17.873 | 22.957 | 18.788 | 11.336 |
| Shareholders Funds | - | - | 2.388 | 7.518 | 8.377 | 4.232 | 28.365 | 23.166 | 32.067 | 10.127 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 6.548 | 4.934 | 276 | 192 | 19.538 | 23.820 | 3.471 | 17.194 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Clinres Farmacija Srl